Results
1 -
8 of
8Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer, International Journal of Clinical Oncology A Phase II Trial of a New 5-Fluorouracil Derivative, BOF-A2 (Emitefur), for Patients with Advanced Gastric Cancer, Surgery Today Improving Fluorouracil Chemotherapy with Novel Orally Administered Fluoropyrimidines, Drugs Oral tegafur/uracil more convenient than fluorouracil, Inpharma Weekly Adverse effects of oral fluorinated pyrimidines well tolerated, Reactions Weekly